| 臺大學術典藏 |
2022-02-21T02:51:54Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali P.A.; Lin C.-C.; Carthon B.C.; Bauer T.M.; Tucci M.; Italiano A.; Iacovelli R.; Su W.-C.; Massard C.; Saleh M.; Daniele G.; Greystoke A.; Gutierrez M.; Pant S.; YING-CHUN SHEN; Perrino M.; Meng R.; Abbadessa G.; Lee H.; Dong Y.; Chiron M.; Wang R.; Loumagne L.; L?pine L.; De Bono J. |
| 臺大學術典藏 |
2022-02-21T23:31:30Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali, Paolo Andrea; Chia-Chi Lin; Carthon, Bradley C.; Bauer, Todd M.; Tucci, Marcello; Italiano, Antoine; Iacovelli, Roberto; Su, Wu Chou; Massard, Christophe; Saleh, Mansoor; Daniele, Gennaro; Greystoke, Alastair; Gutierrez, Martin; Pant, Shubham; YING-CHUN SHEN; Perrino, Matteo; Meng, Robin; Abbadessa, Giovanni; Lee, Helen; Dong, Yingwen; Chiron, Marielle; Wang, Rui; Loumagne, Laure; Lépine, Lucie; De Bono, Johann |
| 臺大學術典藏 |
2022-09-15T01:08:45Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali P.A.; Chia-Chi Lin; Carthon B.C.; Bauer T.M.; Tucci M.; Italiano A.; Iacovelli R.; Su W.-C.; Massard C.; Saleh M.; Daniele G.; Greystoke A.; Gutierrez M.; Pant S.; Shen Y.-C.; Perrino M.; Meng R.; Abbadessa G.; Lee H.; Dong Y.; Chiron M.; Wang R.; Loumagne L.; L?pine L.; De Bono J. |
| 國立成功大學 |
2022 |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali, P.A.;Lin, C.-C.;Carthon, B.C.;Bauer, T.M.;Tucci, M.;Italiano, A.;Iacovelli, R.;Su, W.-C.;Massard, C.;Saleh, M.;Daniele, G.;Greystoke, A.;Gutierrez, M.;Pant, S.;Shen, Y.-C.;Perrino, M.;Meng, R.;Abbadessa, G.;Lee, H.;Dong, Y.;Chiron, M.;Wang, R.;Loumagne, Loumagne L.;L�pine, L�pine L.;De, Bono J. |
| 中國醫藥大學 |
2009-01-21 |
Targeting cell adhesion molecule L1 expression in bone metastatic prostate cancer cells suppresses tumor growth and metastasis by blocking mesenchymal-epithelial transition
|
廖佳慧; 莊珮馨; (I-Hui Wu); 洪明奇(Mien-Chie Hung); (Ira Rajbhandari); (Nicole Johnson); 吳錫金(Wu,Hsi-Chin); (Leland W.K. Chung); 謝嘉玲(Chia-Ling Hsieh)* |
| 國家衛生研究院 |
2015-09 |
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
|
Chi, JY;Hsiao, YW;Li, CF;Lo, YC;Lin, ZY;Hong, JY;Liu, YM;Han, X;Wang, SM;Chen, BK;Tsai, KK;Wang, JM |
| 國立成功大學 |
2015-09-15 |
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
|
Chi, Jhih-Ying; Hsiao, Yu-Wei; Li, Chien-Feng; Lo, Yu-Chih; Lin, Zu-Yau; Hong, Jhen-Yi; Liu, Yang-Ming; Han, Xiu; Wang, Shao-Ming; Chen, Ben-Kuen; Tsai, Kelvin K.; Wang, Ju-Ming |
| 中山醫學大學 |
2021 |
Targeting Chondroitin Sulfate Reduces Invasiveness of Glioma Cells by Suppressing CD44 and Integrin beta 1 Expression
|
Chu, YH; Liao, WC; Ho, YJ; Huang, CH; Tseng, TJ; Liu, CH |
| 臺大學術典藏 |
2020-02-27T06:39:31Z |
Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody
|
Lee P.-C.;Chiou Y.-C.;Wong J.-M.;Peng C.-L.;Ming-Jium Shieh; Lee P.-C.; Chiou Y.-C.; Wong J.-M.; Peng C.-L.; MING-JIUM SHIEH |
| 國立臺灣大學 |
2016 |
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
|
Ning, Sin-Tzu; Lee, Shin-Yu; Wei, Ming-Feng; Peng, Cheng-Liang; Lin, Susan Yun-Fan; Tsai, Ming-Hsien; Lee, Pei-Chi; Shih, Ying-Hsia; Lin, Chun-Yen; Luo, Tsai-Yueh; Shieh, Ming-Jium; 謝銘鈞 |
| 臺大學術典藏 |
2021-07-06T07:01:12Z |
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil
|
Chang C.-K.; Chiu P.-F.; Yang H.-Y.; Juang Y.-P.; Lai Y.-H.; Lin T.-S.; LIH-CHING HSU; Yu L.C.-H.; Liang P.-H. |
| 臺大學術典藏 |
2022-02-15T06:22:44Z |
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil
|
Chang C.-K.; Chiu P.-F.; Yang H.-Y.; Juang Y.-P.; Lai Y.-H.; Lin T.-S.; Hsu L.-C.; LINDA CHIA-HUI YU; Liang P.-H. |
| 臺大學術典藏 |
2021-05-21T11:40:24Z |
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil
|
Chang, Chun Kai; Chiu, Pei Fang; Yang, Hui Yi; Juang, Yu Pu; Lai, Yen Hsun; Lin, Tzung Sheng; LIH-CHING HSU; LINDA CHIA-HUI YU; PI-HUI LIANG |
| 國家衛生研究院 |
2023-08-11 |
Targeting conserved oathways in 3D spheroid Formation of diverse cell types for translational application: Enhanced functional and antioxidant capacity
|
Chang, CC;Jiang, SS;Tsai, FY;Hsu, PJ;Hsieh, CC;Wang, LT;Yen, ML;Yen, BL |
| 中國醫藥大學 |
2007-08-29 |
Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cell by EGCG
|
林慧怡(Lin Hui-Yi); 陳錫?; 余建志(Chien-Chih Yu) |
| 臺北醫學大學 |
2013 |
Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis
|
YC, *Lee;JK, *Jin;CJ, *Cheng;CF, Huang;JH, Song;Huang, M;WS, Brown;Zhang, S;LY, Yu-Lee;ET, Yeh;BW, McIntyre;CJ, Logothetis;GE, Gallick;SH, Lin |
| 臺北醫學大學 |
2013 |
Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis
|
*Lee, YC;*Jin, JK;*Cheng, CJ;Huang, CF;Song, JH;Huang, M;Brown, WS;Zhang, S;Yu-Lee, LY;Yeh, ET;McIntyre, BW;Logothetis, CJ;Gallick, GE;Lin, SH. |
| 國家衛生研究院 |
2017-06-22 |
Targeting coronaviral replication and cellular JAK2 mediated dominant NF-kappaB activation for comprehensive and ultimate inhibition of coronaviral activity
|
Yang, CW;Lee, YZ;Hsu, HY;Shih, C;Chao, YS;Chang, HY;Lee, SJ |
| 義守大學 |
2005-08 |
Targeting customers via discovery knowledge for the insurance industry
|
Chien-Hsing Wu;Shu-Chen Kao;Yann-Yean Su;Chuan-Chun Wu |
| 國家衛生研究院 |
2025-01-03 |
Targeting CXCL7 reduced breast cancer progression and recurrence via reshaping dendritic cells in TME
|
Lin, SC;Yang, YY;Liu, JF;Jang, TH;Chang, WS;Chuang, SE;Wang, LH |
| 臺北醫學大學 |
2018 |
Targeting delivery of Lecithin-Stabilized Micellar Drug Delivery System (LsbMDDs) by Enhanced Permeability and Retention (EPR) effect and Bispecific Antibodies to Enhance Chemotherapeutic Efficacy: Physical and Biopharmaceutical Characterizations
|
蘇家妤; Su, Chia-Yu |
| 臺大學術典藏 |
2020-09-10T01:53:29Z |
Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies
|
S. H. Chen and X. C. Yu; S. H. Chen and X. C. Yu; SHIH-HSUN CHEN |
| 中國醫藥大學 |
2015-03 |
Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models.
|
(Allan V.Kalueff);(Adam Michael Stewart);宋采(Cai Song);(Irving I.Gottesman)* |
| 亞洲大學 |
2005-10 |
Targeting ECM/Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in Bone in a Xenograft Imaging Model. Molecular Therapy
|
Kristen Bisanz;Magnus Edlund;Bill Spohn;Mien-Chie Hung;Leland W. K. Chung |
| 國立臺灣科技大學 |
2016 |
Targeting Ecotourism Market: The Role of Regulatory Focus, Volunteering Experience, and Lifestyle
|
Pertiwi, Husna Putri |
| 國立臺灣大學 |
2008 |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Tseng, Ching-Li; Wu, Steven Yueh-Hsiu; Wang, Wen-Hsi; Peng, Cheng-Liang; Lin, Feng-Huei; Lin, Chien-Cheng; Young, Tai-Horng; Shieh, Ming-Jium |
| 臺大學術典藏 |
2020-02-26T01:33:26Z |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Feng-Huei LinTseng, C.-L.;Wu, S.Y.-H.;Wang, W.-H.;Peng, C.-L.;Lin, F.-H.;Lin, C.-C.;Young, T.-H.;Shieh, M.-J.; Tseng, C.-L.; Wu, S.Y.-H.; Wang, W.-H.; Peng, C.-L.; Lin, F.-H.; Lin, C.-C.; Young, T.-H.; Shieh, M.-J.; FENG-HUEI LIN |
| 臺大學術典藏 |
2020-02-27T03:57:26Z |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Lin F.-H; Lin C.-C; Tai-Horng Young; Shieh M.-J.; Tseng C.-L;Wu S.Y.-H;Wang W.-H;Peng C.-L;Lin F.-H;Lin C.-C;Tai-Horng Young;Shieh M.-J.; Tseng C.-L; Wu S.Y.-H; Wang W.-H; Peng C.-L |
| 國立交通大學 |
2019-04-02T05:58:20Z |
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
|
Liao, Wei-Siang; Ho, Yu; Lin, Yu-Wei; Raj, Emmanuel Naveen; Liu, Kuang-Kai; Chen, Chinpiao; Zhou, Xiao-Zhen; Lu, Kun-Ping; Chao, Jui-I |
| 中國醫藥大學 |
2015-10 |
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
|
(Hsieh YH);(Hsieh SC);李建興(Chien-Hsin Lee);(Yang SF);(Cheng CW);(Tang MJ);(Chia-Liang Lin);(Lin CL);鄒瑞煌(Ruey-Hwang Chou)* |
| 國立成功大學 |
2019-12-17 |
Targeting Endogenous Adduction Level of Serum Albumin by Parallel Reaction Monitoring via Standard Additions and Intact Protein Measurement: Biological Dosimetry of Catechol Estrogens
|
Huang;Yu-Shan;Lin;Yu-Min;Chen;Hsin;Wu;Chih-Hsing;Syu;Chong-Hua;Huang;Ting-En;Do;Quynh-Trang;Chen;Shu-Hui |
| 臺大學術典藏 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih; Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 國立臺灣大學 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 臺大學術典藏 |
2018-09-10T08:29:51Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin, S.-L. and Chang, F.-C. and Schrimpf, C. and Chen, Y.-T. and Wu, C.-F. and Wu, V.-C. and Chiang, W.-C. and Kuhnert, F. and Kuo, C.J. and Chen, Y.-M. and Wu, K.-D. and Tsai, T.-J. and Duffield, J.S.; VIN-CENT WU; SHUEI-LIONG LIN; TUN-JUN TSAI; WEN-CHIH CHIANG; YUNG-MING CHEN |
| 臺大學術典藏 |
2020-09-28T07:05:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Duffield J.S.; Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Chiang W.-C.; Kuhnert F. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Yung-Ming Chen;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; YUNG-MING CHEN; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Schrimpf C.; Chang F.-C.; Lin S.-L.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; TUN-JUN TSAI; Duffield J.S. |
| 臺大學術典藏 |
2020-12-24T08:38:29Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
WEN-CHIH CHIANG; Wu V.-C.; Chen Y.-T.; Wu C.-F.; Schrimpf C.; Chang F.-C.; Lin S.-L.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Wen-Chih Chiang;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Duffield J.S.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-23T02:58:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Kuhnert F.; Chiang W.-C.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Vin-Cent Wu;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T03:44:00Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; FAN-CHI CHANG; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T23:47:26Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; YI-TING CHEN; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-11-30T04:54:30Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-01-12T03:32:22Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Shuei-Liong Lin;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; SHUEI-LIONG LIN; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 國立臺灣大學 |
2011 |
Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple- Negative Breast Cancer by a Novel Adenosine Monophosphate-Activated Protein Kinase (Ampk) Activator
|
顧記華; 楊小青; 陳慶士; GUH, JIH-HWA; YANG, HSIAO-CHING; CHEN, CHING-SHIH |
| 臺大學術典藏 |
2021-06-02T05:43:48Z |
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
|
Lee K.-H.; Hsu E.-C.; JIH-HWA GUH; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. |
| 臺大學術典藏 |
2021-06-04T03:09:10Z |
Targeting ENT1 and adenosine tone for the treatment of Huntington's disease
|
Kao Y.-H.;Lin M.-S.;Chen C.-M.;Wu Y.-R.;Chen H.-M.;Lai H.-L.;Chern Y.;Chun-Jung Lin; Kao Y.-H.; Lin M.-S.; Chen C.-M.; Wu Y.-R.; Chen H.-M.; Lai H.-L.; Chern Y.; CHUN-JUNG LIN |
| 臺北醫學大學 |
2006 |
Targeting epidermal growth factor receptor in lung cancer: Perspective from the Asia–Pacific region
|
劉興璟; Liu HE; Lim KH; Huang MJ; Huang BS |
| 臺大學術典藏 |
2021-02-02T00:46:32Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:49Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:06Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; KAI-YUAN TZEN; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
